CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugarThe EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment Share XCHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugarhttps://pharmaphorum.com/news/chmp-backs-lillys-baqsimi-as-non-injectable-for-severe-low-blood-sugar/
Xeris’ severe low blood sugar pen gets FDA approvalAfter 14 years of operations Xeris Pharma has its first-ever product approval, claiming an FDA okay for a Share XXeris’ severe low blood sugar pen gets FDA approvalhttps://pharmaphorum.com/news/xeris-severe-low-blood-sugar-pen-gets-fda-approval/
FDA clears Lilly’s rescue med for severe hypoglycaemia in diabeticsThe US regulator has approved the first non-injectable emergency medicine for diabetics who suffer potentially fatal low blood Share XFDA clears Lilly’s rescue med for severe hypoglycaemia in diabeticshttps://pharmaphorum.com/news/fda-clears-lillys-rescue-med-for-severe-hypoglycaemia-in-diabetics/
